Vox Markets Logo
22nd May 2023
07:15

OKYO Pharma Limited - London Stock Exchange Delisting

22nd May 2023
07:00

Stock Exch Notice - Cancellation - OKYO PHARMA LIMITED

19th May 2023
07:00

OKYO Pharma Limited - ADS Program collapse

15th May 2023
06:00

OKYO Pharma Limited - Change of Record Time and Last Day of Dealings

11th May 2023
11:00

OKYO Pharma Limited - Webull Corporate Communications Service Platform

11th May 2023
06:00

OKYO Pharma Limited - Change of Delisting Date to 22 May 2023

3rd May 2023
12:00

OKYO Pharma Limited - Result of Meeting

3rd May 2023
06:00

OKYO Pharma Limited - Presentation on OK-101 at ASCRS

2nd May 2023
06:00

OKYO Pharma Limited - First-Patient First-Visit for Phase 2 Trial

25th April 2023
06:00

OKYO Pharma Limited - Activation of First Clinical Trial Site in the U.S

5th April 2023
06:00

OKYO Pharma Limited - NOTICE OF GENERAL MEETING AND CIRCULAR PUBLICATION

4th April 2023
06:00

OKYO Pharma Limited - Notice Of Intention To Delist From The LSE

30th March 2023
06:00

OKYO Pharma Limited - Director Acquires Shares

29th March 2023
06:00

OKYO Pharma Limited - Director acquires shares

24th March 2023
07:00

OKYO Pharma Limited - Director/PDMR Shareholding

16th March 2023
07:01

OKYO Pharma Limited - Listing of Trial on the ClinicalTrials.gov Website

16th March 2023
07:00

OKYO Pharma Limited - Closing of Global Private Placement

15th March 2023
07:01

OKYO Pharma Limited - Director/PDMR Dealings

14th March 2023
07:00

OKYO Pharma Limited - Issue of Equity

OKYO Pharma Corp. (OKYO.L) Share Price & News


Bid
-
-
-
Ask
  • High
    -
  • OPEN
    -
  • VOL
    -
  • MKT CAP
    -M
  • LOW
    -
  • CLOSE
    -
  • SHARES IN ISSUE
    1.66B

OKYO Pharma Corp. Company Profile

OKYO Pharma Limited (LSE: OKYO) is a life sciences and biotechnology company admitted to listing on the standard segment of the Official List of the UK Financial Conduct Authority and to trading on the Main Market for listed securities of the London Stock Exchange plc.

Watchlist